Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts activation of protein synthesis after resistance exercise in human skeletal muscle by Gnimassou, Olouyomi et al.
  1 
Title  
Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts 
activation of protein synthesis after resistance exercise in human skeletal muscle 
 
Authors 
Olouyomi Gnimassou
1
, Rodrigo Fernández-Verdejo
1
, Matthew Brook
2
, Damien Naslain
1
, 
Estelle Balan
1
, Mariwan Sayda
2
, Jessica Cegielski
2
, Henri Nielens
1
, Anabelle Decottignies
3
, 
Jean-Baptiste Demoulin
3
, Kenneth Smith
2
, Philip J Atherton
2
, Marc Francaux
1
, Louise 
Deldicque
1*
 
 
1
Institute of Neuroscience, Université catholique de Louvain, Louvain-la-Neuve, Belgium 
2
Medical Research Council-Arthritis Research UK Centre of Excellence for Musculoskeletal 
Ageing Research and Clinical, Metabolic, and Molecular Physiology, University of 
Nottingham, Royal Derby Hospital, Derby, United Kingdom 
3
de Duve Institute, Université catholique de Louvain, Brussels, Belgium 
 
*Corresponding author: Louise Deldicque 
Address: Place Pierre de Coubertin, 1 Box L08.10.01, 1348 Louvain-la-Neuve, Belgium 
Phone number: +32 10 47 44 43 
e-mail: louise.deldicque@uclouvain.be 
 
Short title: Muscle adaptations to hypoxic resistance exercise 
  
  2 
Abbreviations: 
1-RM: one repetition maximum 
ACC: acetyl CoA carboxylase 
Akt/PKB: protein kinase B 
AMPK: adenosine monophosphate-activated protein kinase 
Atg: autophagy related-gene 
Bnip3: Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3 
Bnip3L: Bnip3 like 
CoCl2: cobalt chloride 
Ctrl: control 
D2O: deuterium 
D-3MH: 3D-methyl-histidine 
EDTA: ethylenediaminetetraacetic acid 
EGTA: ethylene glycol tetraacetic acid 
Ex: exercise 
HIF-1α: hypoxia-inducible factor-1α 
HR: heart rate 
HYP: hypoxia 
LC3b: microtubule-associated protein 1 light chain 3 
Lox: lipoxygenase 
Mafbx: muscle atrophy F box 
mTOR: mammalian target of rapamycin 
MuRF-1: muscle ring finger protein-1 
Mrf4: myogenic regulatory factor 4 
Myf-5: myogenic factor 5 
Myh: myosin heavy chain 
NIRS: near-infrared spectroscopy 
NOR: normoxia 
Pcna: proliferating cell nuclear antigen 
Pdk4: pyruvate dehydrogenase kinase isoform 4 
Pfk: phosphofructokinase 
Plin2: perilipin 2 
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RPL: ribosomal protein L 
S6: ribosomal S6 protein 
S6K1: ribosomal S6 kinase 1 
SpO2: peripheral blood oxygen saturation 
Redd1: regulated in development and DNA damage response 1 
Tnni1: troponin I1, slow skeletal type 
Tnnt1: troponin T1, slow skeletal type 
TSI: tissue saturation index 
ULK1: Unc51-like kinase 1 
Vegf: vascular endothelial growth factor 
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Abstract 
We hypothesized that a single session of resistance exercise performed in moderate 
environmental hypoxic conditions would potentiate the anabolic response during the recovery 
period spent in normoxia. Twenty subjects performed a one-leg knee extension session in 
normoxic or hypoxic (FiO2: 14%) conditions. Muscle biopsies were taken 15min and 4h after 
exercise in the vastus lateralis of the exercised and the non-exercised legs. Blood and saliva 
samples were taken at regular intervals before, during and after the exercise session. The 
muscle fractional protein synthetic rate was determined using deuterium incorporation into 
proteins and the protein degradation rate by methylhistidine release from skeletal muscle. We 
found that: 1) hypoxia blunted the activation of protein synthesis after resistance exercise; 2) 
hypoxia down-regulated the transcriptional program of autophagy; 3) hypoxia regulated the 
expression of genes involved in glucose metabolism at rest, and genes involved in myoblast 
differentiation and fusion, and in muscle contraction machinery after exercise; 4) the hypoxia-
inducible factor-1α pathway was not activated at the time points studied. Contrary to our 
hypothesis, environmental hypoxia did not potentiate the short-term anabolic response after 
resistance exercise, but it initiated transcriptional regulations that could potentially translate 
into satellite cells incorporation and higher force production on the long-term. 
 
Keywords: hypoxia-inducible factor, deuterium, autophagy, redd1, tissue oxygenation index 
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Introduction 
Hypoxia is a state of lowered oxygen tension in tissue that can be created by environmental 
conditions such as high altitude, or by pathological conditions such as chronic obstructive 
pulmonary disease (1) and obstructive sleep apnea (2). During exercise, hypoxia can also be 
generated but, contrary to the previous situations, oxygen restriction is then limited to skeletal 
muscle (3). Whatever the origin of hypoxia, different tissues will adapt acutely and/or 
chronically to deal with this reduction in oxygen availability. Interestingly, hypoxia has 
recently emerged as a particularly efficient stimulus to stimulate muscle cell proliferation and 
accretion of muscle mass (4). While long lasting hypoxia generally leads to a negative 
regulation of protein metabolism and a loss of muscle mass (5-7), repeated intermittent 
hypoxia seems to rather exert a positive effect on protein balance (4). Thus, hypoxic 
resistance training has become popular amongst athletes as it is thought to favor muscle 
accretion. Indeed, previous observations suggest that muscle hypertrophy can be optimized 
when resistance training is performed in a hypoxic environment (8, 9). However, the 
molecular mechanisms are largely unknown.  
Skeletal muscle mass reflects a dynamic turnover between net protein synthesis and 
degradation. In addition, satellite cell inclusion may contribute to increase muscle mass, while 
fiber loss results in a reduction of muscle mass. While controversial (10), protein synthesis is 
regularly assessed by measuring the activation of the protein kinase B (Akt/PKB)/mammalian 
target of rapamycin (mTOR) pathway and its downstream targets ribosomal S6 kinase 1 
(S6K1) and ribosomal S6 protein (S6). Muscle protein degradation is mainly regulated by the 
autophagy-lysosomal and the ubiquitin–proteasome pathways. The latter mechanism is 
largely regulated by E3 ligases such as muscle atrophy F box (Mafbx) and muscle ring finger 
protein-1 (MuRF-1) (11). The transcriptional regulation of those E3 ligases is partly 
controlled by the members of the forkhead FoxO family, themselves regulated by Akt (12). 
Unc51-like kinase 1 (ULK1) plays an essential role in the initiation of autophagy and more 
specifically in the autophagosome membrane formation (13). The subsequent elongation of 
the membrane is under the control of several autophagy related-gene (Atg) proteins, including 
microtubule-associated protein 1 light chain 3 (LC3b). The mature autophagosome, whose 
membrane includes the lipidated form of LC3 (LC3bII), fuses with lysosomes containing 
hydrolases. As mentioned earlier, satellite cells may contribute to muscle hypertrophy as well 
(14). Their activation, proliferation and differentiation are tightly controlled by the so-called 
myogenic regulatory factors, namely myogenin, MyoD, myf-5 and myogenic regulatory 
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factor 4 (Mrf4) (14). At a molecular level, a decrease in oxygen tension activates the hypoxia-
inducible factor-1α (HIF-1α), which is responsible for many responses to hypoxic conditions 
such as angiogenesis or increased glucose metabolism, via increased gene expression of 
vascular endothelial growth factor (Vegf) and phosphofructokinase (Pfk), respectively (15). 
Whether HIF-1α is directly responsible for the regulation of protein metabolism under 
hypoxic conditions is unknown.  
Due to the lack of data, the purpose of the present study was to determine the rates of protein 
synthesis and protein degradation as well as the molecular adaptations after resistance 
exercise in hypoxia in human skeletal muscle. We hypothesized that one session of resistance 
exercise performed in moderate environmental hypoxic compared to normoxic conditions 
would potentiate the anabolic response during the recovery period spent in normoxia. 
 
Materials and methods 
Subjects 
Twenty young, physically active, men gave their written informed consent to participate in 
the study (BMI 22.2 ± 0.3kg/m
2
, age 22.2 ± 0.4y). The experiment was approved by the 
ethical committee of the Université catholique de Louvain and conducted in accordance with 
the declaration of Helsinki. The exclusion criteria were: cardiovascular or pulmonary disease, 
chronic medication, any contraindication to resistance training or having been exposed to an 
altitude above 1500m during the month before the experiment. 
Protocol 
The subjects were randomly distributed into two groups, hypoxia (HYP, n=10) or normoxia 
(NOR, n=10) (Fig. 1). Each subject came 3 times to the laboratory. 
First visit: A week before the experiment, height and weight were determined. The one-
repetition maximum (1-RM) of the right leg was determined on a knee extension device (Pro-
Dual Body Solid).  
Second visit: The day before the experiment, saliva and blood samples were collected prior to 
ingestion of deuterium oxide (400ml spread over 2h, Sigma-Aldrich #613428, Overijse, 
Belgium) and 3D-methyl-histidine (10mg diluted in 100ml water, Cambridge Isotope 
Laboratories DLM-2949-MPT-PK, Apeldoorn, The Netherlands). A second sample of saliva 
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was collected 90min after ingestion of the last dose of deuterium. Thereafter, a standardized 
low meat spaghetti bolognese was provided.  
Third visit: The day after the second visit, the subjects came to the laboratory in the fasted 
state. After collection of blood, saliva and urine samples (Fasted), they received a 
standardized meat-free breakfast complemented with 10g essential amino acids. One hour 
after meal consumption, the one-leg knee extension exercise session began (8 sets of 8 
repetitions at 80% 1-RM, 2-min rest between sets) either in normoxic or hypoxic (FiO2: 14%) 
conditions. Each set lasted about 25s to be completed. In total, the whole session, and thereby 
the exposition to hypoxia or normoxia, lasted for 30min. During exercise, vastus lateralis 
muscle oxygenation was monitored by near-infrared spectroscopy (NIRS) (Artinis, Elst, The 
Netherlands), and peripheral blood oxygen saturation (SpO2) and heart rate (HR) were 
monitored by pulse oximetry (TCM Tosca, Radiometer, Zoetermeer, The Netherlands). 
Blood, saliva and urine samples were collected immediately (Post), 2h (2h Post) and 4h after 
exercise (4h Post). Muscle biopsies were taken from the vastus lateralis of the exercised and 
non-exercised (control) legs within 15min after exercise (Post) and 4h after exercise (4h Post). 
Near-infrared spectroscopy 
Changes in muscle oxygenation were measured by NIRS using the difference in absorption 
characteristics of light between 760nm and 850nm (Portamon, Artinis). Tissue saturation 
index (TSI, %) was monitored at baseline (30-s averaging before the start of the first set) and 
during each set. As described in Brocherie et al. (16), the apparatus was fixed with a large 
bandage to avoid interference by extraneous light and loss of transmitted light out of the field 
of investigation.  
Samples collection and storage 
Blood: Samples were taken in an antecubital vein in two 5-ml tubes containing 
ethylenediaminetetraacetic acid (EDTA) and immediately put on ice until centrifugation. 
After centrifugation at 4°C for 10min at 3000g, plasma was transferred to microtubes and 
stored at -80°C. 
Saliva: Samples were collected with a cotton wool, gently chewed during 1 to 2min. The 
swab was then placed in the suspended insert and the salivette was firmly closed using the 
stopper. The samples were immediately placed on ice until centrifugation. The salivettes were 
then centrifuged at 3°C for 10min at 3000g. The supernatant was aliquoted and stored at -
20°C. 
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Urine: Samples were collected in 2-l bottles, transferred and aliquoted in 50-ml tubes and 
immediately stored at -20°C. 
Muscle biopsies: Vastus lateralis muscle biopsies were taken according to the modified 
Bergström technique with suction. After local anesthesia (xylocaine 2% without adrenaline, 
Astra Zeneca, Uccle, Belgium), a 5-mm incision was made with a scalpel and a pressure 
applied for 10min to reduce blood flow. The Bergström needle was then gently inserted into 
the incision, at least 1cm beyond the fascia, to reach the muscle and three successive cuts 
were performed to obtain 150mg per sample. The samples were immediately frozen in liquid 
nitrogen and stored at -80°C. 
Plasma insulin and cortisol concentrations 
Plasma concentration of insulin and cortisol were determined by ELISA using the 
ultrasensitive insulin kit from Mercodia (Uppsala, Sweden) and the human cortisol kit from 
Abcam (Cambridge, UK), respectively. 
Protein extraction 
Muscles samples were homogenized with a Polytron mixer in ice-cold lysis buffer (20mM 
Tris–HCl pH 7.0, 270mM sucrose, 5mM ethylene glycol tetraacetic acid (EGTA), 1mM 
EDTA, 1mM sodium orthovanadate, 50mM B-glycerophosphate, 5mM sodium 
pyrophosphate, 50mM sodium fluoride, 1mM DTT, 1% Triton-X 100 and a complete 
protease inhibitor tablet), centrifuged at 10.000g for 10min at 4°C and the supernatant 
aliquoted and stored at -80°C. The pellet, containing non-soluble proteins, was stored at -
80°C for the determination of the protein synthetic rate. The myofibrillar fraction was isolated 
from the pellet by the addition of 0.3M NaOH and placed at 37
o
C for 30min. The non-soluble 
collagen proteins were removed by centrifugation and the myofibrillar proteins precipitated 
with 1M PCA. Protein bound amino acids were released using acid hydrolysis in 0.1M HCl 
and Dowex H+ resin slurry overnight before being eluted from the resin with 2M NH4OH and 
evaporated to dryness. The DC protein assay kit was used to determine the protein 
concentration of each sample using bovine serum albumin as a standard (Bio-Rad, Nazareth, 
Belgium).  
Western Blotting  
Thirty to seventy μg proteins were separated by SDS-PAGE (8%-15% gels) and transferred to 
PVDF membranes. Membranes were blocked with 5% non-fat milk for 1h and incubated 
overnight at 4°C with one of the following antibodies: phospho-AMP activated protein kinase 
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(AMPK, Thr
172
), total-AMPK, phospho-S6K1 (Thr
389
), total-S6K1, phospho-Akt (Ser
473
), 
total-Akt, phospho-FoxO1 (Thr
24
)/FoxO3a (Thr
32
), total-FoxO1/FoxO3a, phospho-S6 
(Ser
235/236
), total S6, phospho-acetyl CoA carboxylase (ACC, Ser
79
), total-ACC, 
p62/SQSTM1, HIF-1α (all from Cell Signaling, Leiden, The Netherlands, 1:1000, BSA 1%), 
regulated in development and DNA damage response 1 (Redd1, ProteinTech, 1:750, BSA 
1%), LC3b (Sigma-Aldrich, 1:1000, milk 5%). Secondary anti-mouse (1:10000) or anti-rabbit 
(1:5000) antibodies conjugated to horseradish peroxidase were used for detection of proteins 
of interest. Membranes were thereafter scanned and proteins quantified with GeneSnap 
software and tools (Syngene, Cambridge, UK). For detection of total protein forms, 
membranes were stripped and re-probed with the antibody for the total form of the respective 
protein to ascertain the relative amount of the phosphorylated protein compared with the total 
form throughout the whole experiment. The results are presented as the ratio 
phosphorylated/total form of the protein and are expressed in arbitrary units. 
Protein synthesis and protein degradation 
The muscle fractional synthetic rate was determined using the stable isotope deuterium 
following the same procedure as in Wilkinson et al (17). The muscle protein degradation rate 
was determined using the stable isotope tau-methyl-l-histidine based on the procedure 
described in Sheffield-Moore et al (18). Both rates were determined between 15min and 4h 
post-exercise. 
Immunofluorescence 
Cryosections of 6μm thickness were fixed with 3.7% formaldehyde for 10min and incubated 
in a permeabilization buffer (20mM Tris-HCl pH 8.0, 50mM NaCl, 3mM MgCl2, 300mM 
sucrose, 0.5% Triton X-100) at 37°C for 20min. After blocking nonspecific staining with 1% 
normal goat serum (NGS) in phosphate buffered saline (PBS) for 30min, sections were 
incubated with an anti-HIF1α (1:25 in 1% NGS diluted in PBS, Cell Signaling) overnight at 
4°C, followed by incubation with a goat anti-rabbit IgG AF 488 (1:200 in 1% NGS diluted in 
PBS, Invitrogen, Merelbeke, Belgium) for 1h at room temperature. Nuclei were identified 
with 4’,6-diaminido-2-phenylindole (DAPI) provided in the mounting medium (Vectashield, 
Vector Laboratories Inc, Brussels, Belgium). Specimens were examined with a Zeiss Axio 
Vert.A1 fluorescence microscope. HeLa cells and human myotubes treated with 400μM 
CoCl2 for 24h were used as a positive control. 
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RNA extraction and real-time PCR 
About 20-25mg of muscle biopsy sample was homogenized in 1ml Trizol reagent (Invitrogen, 
Merelbeke, Belgium) using a Polytron mixer. RNA isolation was achieved according to the 
manufacturer’s instructions. RNA quality and quantity were assessed by Nanodrop 
spectrophotometry. Reverse transcription was performed from 1µg RNA using the 
iScriptcDNA Synthesis Kit from Bio-Rad, following the manufacturer’s instructions. The 
primers used are presented in Table 1. PCR was run using the following conditions: 3min at 
95°C, followed by 35 cycles of 30s at 95°C, 30s at 60°C, and 30s at 72°C. All samples were 
run in duplicate and each reaction was processed in a 10µl volume containing 4.8µl IQ 
SybrGreen SuperMix (Bio-Rad), 0.1µl of each primer (100nM final), and 5µl cDNA at the 
appropriate dilution. Melting curves were systematically performed for quality control. To 
compensate for variations in input RNA amounts and efficiency of reverse transcription, 
ribosomal protein L4 (RPL4) and RPL19 mRNA were quantified, and results were 
normalized to these values. These genes were chosen out of four normalization genes using 
the GeNorm applet according to the guidelines and theoretical framework described 
elsewhere (19). The results are expressed in arbitrary units. 
Microarray 
Microarray analyses were performed on biopsies obtained 4h after exercise in the exercised 
and non-exercised control legs in NOR and in HYP. Bioanalyzer nano 6000 chips (Agilent 
Technologies, Santa Clara, CA, USA) were used to assess RNA quality. Only samples with 
an RNA integrity number > 7.7 were used. We thus selected subjects in normoxia (n=8) and 
hypoxia (n=7), and then pooled their RNA for each condition, i.e. NOR.Rest, NOR.Exercise, 
HYP.Rest, and HYP.Exercise. GeneChip Human Transcriptome Array 2.0 and GeneChip WT 
PLUS Reagent Kit were used following manufacturer’s instructions (Affymetrix, Santa Clara, 
CA, USA). Affymetrix Transcriptome Analysis Console Software was used to compute gene 
signals. Functional annotation and pathway analysis for comparisons at rest (HYP.Rest vs. 
NOR.Rest) and after exercise (HYP.Exercise vs. NOR.Exercise) were performed with 
DAVID web tool (20). In the DAVID analyses, Fischer exact p-values < 0.05, which are 
equivalent to –log10(p-value) > 1.3, were considered statistically significant.  
Statistics 
All values are expressed as means ± SEM. Repeated measures ANOVA was performed 
considering groups (HYP or NOR) as inter-group factor, and time (15min post-exercise and 
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4h post-exercise) and condition (rest and exercise) as intra-group factors. Corrected 
Bonferroni post-hoc analyses were performed when indicated, and statistical significance was 
fixed at p<0.05. All statistical analyses were performed using the Statistical Package for the 
Social Sciences (SPSS Inc version 24.0). 
 
Results 
Blood but not muscle oxygenation was decreased in hypoxia 
SpO2 was about 98% at baseline and during each set in normoxia (Table 2). In hypoxia, SpO2 
decreased to ~93% at baseline, and was lower compared to normoxia during the whole 
experiment (p<0.001). From the 2nd set in hypoxia, SpO2 increased compared to baseline 
reaching 94.6 to 95.1% (p<0.05). TSI decreased by about 10 to 15% during exercise 
(p<0.001) but was not different between normoxia and hypoxia. Heart rate progressively 
increased during exercise (p<0.001), with no difference between normoxia and hypoxia (+ 30 
beats/min in normoxia and + 25 beats/min in hypoxia). Plasma insulin levels were higher at 
Post (after breakfast) compared to Fasted in both normoxia and hypoxia (p<0.001, Table 3), 
as expected. No difference in plasma insulin concentrations was observed between normoxia 
and hypoxia, although a trend to higher values in hypoxia was measured at 2h Post (p=0.061). 
Compared to Fasted, plasma cortisol concentrations were lower at Post, 2h Post and 4h Post 
(p<0.05), with no difference between normoxia and hypoxia. 
Hypoxia blunts the activation of protein synthesis after resistance exercise 
The fractional synthetic rate was increased by about 40% after resistance exercise in 
normoxia (p=0.023, Fig. 2a), but not in hypoxia. The fractional synthetic rate was not 
different between normoxia and hypoxia in the control rested leg. 
No effect of hypoxia on the mTOR pathway despite decreased AMPK phosphorylation 
We next analyzed the phosphorylation state of key mediators of the mTOR pathway. 
Compared to Post, the phosphorylation of Akt, S6K1 and S6 were lower at 4h Post in the 
exercised leg in normoxia and hypoxia (p<0.001, Fig. 2b-d). Compared to Post, phospho-Akt 
(p=0.004) and phospho-S6 (p=0.036) were lower at 4h Post in the control leg only in hypoxia, 
while phospho-S6K1 was lower in both normoxia (p=0.012) and hypoxia (p=0.004). In 
addition, phospho-S6K1 was higher in the exercised leg compared to the control leg at Post in 
normoxia (p=0.016), and at 4h Post in hypoxia (p=0.012). Compared to the control leg, 
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phospho-S6 was higher in the exercised leg at Post in normoxia (p=0.012) and hypoxia 
(p=0.012). The expression of the mTOR inhibitor Redd1 was lower at 4h Post in the exercised 
leg compared to the control leg in both normoxia (p=0.020) and hypoxia (p=0.050) (Fig. 2e). 
Hypoxia lowered Redd1 protein expression at 4h Post in the control (p=0.047) and in the 
exercised leg (p=0.041). Hypoxia decreased phospho-AMPK at Post in the control leg 
(p=0.022) and at 4h Post in the exercised leg (p=0.001) (Fig. 2f). As a readout of AMPK 
activity, we also tested the phosphorylation of its substrate ACC. Compared to Post in the 
exercised leg, phospho-ACC was lower at 4h Post in normoxia (p=0.040) and in hypoxia 
(p=0.004) (Fig. 2g). Exercise increased phospho-ACC in hypoxia (p=0.004) and tended to 
increase it in normoxia (p=0.084).  
Hypoxia down-regulated autophagy transcriptional regulation 
The muscle protein degradation rate, assessed by the rate of 3-D-methyl-histidine 
disappearance from the plasma, was similar between normoxia and hypoxia (Fig. 3a). 
LC3bII/I ratio increased in both legs at 4h Post in normoxia and hypoxia (p<0.01, Fig. 3b). 
This increase was partially repressed by exercise in normoxia (p=0.012) as well as in hypoxia 
(p=0.004). A trend to a main exercise effect was observed for p62 (p=0.096, Fig. 3c). Bcl-
2/adenovirus E1B 19 kDa protein-interacting protein 3 (Bnip3, Fig. 3d) and Bnip 3 like 
(Bnip3L, Fig. 3e) mRNA levels were lower at all time points studied in hypoxia compared to 
normoxia (p<0.05). Compared to Post, Bnip3 mRNA was lower in the control leg in hypoxia 
(p=0.036) and tended to be lower in the exercised leg in normoxia at 4h Post (p=0.072). 
Compared to Post, Bnip3L mRNA was lower in the exercised leg in hypoxia at 4h Post 
(p=0.024). Similarly, Lc3b mRNA was lower in hypoxia compared to normoxia (p<0.05) 
except at Post in the control leg (Fig. 3f). Compared to Post, Lc3b mRNA was lower in the 
control leg in hypoxia at 4h Post (p=0.016). Atg12 mRNA levels were not modified by any 
condition (Fig. 3g). Compared to normoxia, pFoxO was higher in hypoxia at 4h Post in the 
exercised leg (p=0.047) and tended to be higher at the same time point in the control leg 
(p=0.072) (Fig. 3h). Murf-1 mRNA levels were higher at 4h Post in the exercised leg 
compared to the control leg (p=0.024) (Fig. 3i). Compared to Post in hypoxia, Mafbx mRNA 
levels were lower at 4h Post in both the control (p=0.004) and exercised leg (p=0.016) (Fig. 
3j). 
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Hypoxia differentially regulated gene expression at rest and after exercise 
Microarray analyses showed that hypoxia up- or down-regulated by at least 1.5-fold a total of 
392 genes at rest and 480 genes 4h after exercise (see Fig. 4a for selected genes, and 
Supplementary file 1 for the full list). Analyses of functional annotation and signaling 
pathways revealed that, at rest, hypoxia influenced glucose metabolism and oxygen transport 
(Fig. 4b and Supplementary file 1). Similar analyses after exercise revealed that hypoxia 
influenced myoblast differentiation and fusion, and several components of the muscle 
contraction machinery (Fig. 4c and Supplementary file 1). Focusing on hypoxia-induced 
changes, qPCR analyses confirmed that Myh1 mRNA levels were increased while Tnnt1 
mRNA levels were decreased in hypoxia compared to normoxia (p<0.05, Supplementary file 
2).  
Hypoxia regulated markers for cell differentiation but not proliferation 
The mRNA levels of Fos were lower at 4h Post compared to Post in all conditions (p<0.05, 
Fig. 5a). At Post, Fos mRNA levels were higher in the exercised leg compared to the control 
leg in both normoxia and hypoxia (p<0.01). In addition, at Post, Fos mRNA levels were 
higher in hypoxia in the control leg (p=0.012) and tended to be higher in the exercised leg 
(p=0.098). The mRNA levels of Cyclin D1 were higher in the exercised leg compared to the 
control leg at 4h Post in hypoxia (p=0.028, Fig. 5c) The mRNA levels of Pcna were lower in 
the exercised leg compared to the control leg at 4h Post in normoxia (p=0.020, Fig. 5c). The 
mRNA levels of p21 were similarly increased by exercise at 4h Post in normoxia and in 
hypoxia (p<0.05, Fig. 5d). Myf5 mRNA levels were not modified by any condition (Fig. 5e). 
A time (p=0.006) and an exercise (p=0.046) effects were found for MyoD (Fig. 5f). The 
mRNA levels of myogenin were higher in hypoxia compared to normoxia in the control leg at 
Post (p=0.009) and tended to be higher at 4h Post compared to Post in the exercised leg in 
hypoxia (p=0.072). Mrf4 mRNA levels were decreased 4h Post compared to Post in both 
normoxia and hypoxia in the control leg as well as in the exercised leg (p<0.05, Fig. 5h). In 
addition, exercise increased the mRNA levels of Mrf4 at 4h Post in both normoxia (p=0.016) 
and hypoxia (p=0.008) and at Post in hypoxia only (p=0.044).  
Hypoxia-inducible factor pathway was not modified by any condition 
Neither the localization (Fig. 6a, Supplementary file 3), the protein expression (Fig. 6b), nor 
the mRNA levels (Fig. 6c) of HIF-1α was modified by any condition. Similar results were 
found for Hif-2α (Fig. 6d) and Plin2 (Fig. 6g) mRNA levels. Vegf mRNA levels were higher 
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4h Post in normoxia (p=0.004) and tended to be higher in hypoxia (p=0.064) compared to 
Post (Fig. 6e). In addition Vegf mRNA was higher in the exercised leg 4h Post compared to 
the control leg in both normoxia (p<0.001) and hypoxia (p=0.024). A main time effect was 
observed for Lox mRNA levels (p=0.032, Fig. 6f), with lower values at 4h Post compared to 
Post. 
Discussion 
Skeletal muscle adapts to hypoxia and resistance training. Combining both stimuli 
intermittently seems an effective strategy to favor muscle hypertrophy (21-23), even if the 
molecular bases remain unclear. To the best of our knowledge, only one study focused on the 
regulation of protein metabolism after an acute hypoxic resistance exercise in human (24). 
Muscle protein synthesis was blunted by hypoxia after resistance training, but no amino acids 
were provided to favor muscle anabolism and the hypoxic conditions were harsher (12% for 
3.5h) than the one typically used by sportsmen (14-15% O2 for 30min to 1h). As the hypoxic 
dose is crucial for the regulation of muscle mass (25), we hypothesized that different doses 
could induce different responses and a resistance exercise session performed in a moderate 
environmental hypoxia could induce a positive protein balance and favor muscle mass 
accretion when repeated (26). Contrary to our hypothesis, a lower dose of hypoxia blunted 
protein synthesis as well. This is surprising because an inverse correlation has been previously 
found between SpO2 and the fractional synthetic rate after resistance exercise, with the lowest 
rates being measured in subjects displaying SpO2 below 85% (24). Here, SpO2 averaged 93-
94% in the hypoxic group and still protein synthesis did not increase after exercise. As we 
found no relationship between SpO2 or TSI and the protein synthetic rate (data not shown), 
we looked for other possible molecular mechanisms that could have led to the lack of 
activation of protein synthesis after resistance exercise in hypoxia. We have previously found 
that the Akt/mTOR pathway at rest (27) and the autophagy pathway after endurance exercise 
(28) were modulated by hypoxia. Here, despite a reduced phosphorylation of AMPK and a 
reduced expression of Redd1, the activation of the Akt/mTOR pathway after exercise was not 
modified in hypoxia. These results indicate that the activation of AMPK (29) and Redd1 (30) 
was not sufficient to inhibit the Akt/mTOR pathway or that this inhibitory role was overruled 
by another undetermined signal. One of those signals could have been insulin, as it has been 
previously related to an activation of the Akt/mTOR pathway under hypoxic conditions (27). 
Insulin increased after breakfast in our study, but this increase was not modulated by the 
environmental conditions in which exercise was performed. Those results suggest that 
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hypoxia did not blunt protein synthesis through a decrease in insulin concentrations and 
down-regulation of the Akt/mTOR pathway. 
For the first time, the muscle protein degradation rate was measured after hypoxic training. 
We found that the protein degradation rate was similar after normoxic and hypoxic training. 
Unfortunately, the technique used to determine the muscle degradation rate, i.e. the rate of 
disappearance of 3-D-methyl-histidine from the plasma (18), only allows comparison between 
normoxia and hypoxia, not between the rested and the exercised leg. The only study having 
determined the rate of muscle protein degradation in hypoxic conditions was made in rats 
exposed to severe hypobaric hypoxia (7620m) for 14 days (31). The degradation rate was 
higher after 3 days of exposure and increased further after 14 days. As those conditions 
profoundly differ from ours (species, duration of exposure, hypoxic dose, exercise), no 
comparison is possible. Though, we ensure the values we obtained were in the range of those 
reported previously for both protein synthesis (17) and protein degradation (18) with the same 
techniques. While calculation of the net protein balance was not possible due to the use of two 
different isotopes, we can speculate that the exercise session in normoxia induced a more 
favorable balance than in hypoxia, contrary to our hypothesis. 
A similar global protein degradation rate did not exclude that specific proteolytic processes 
were regulated by hypoxia or that protein degradation was differently regulated in the 
exercised and in the control leg. Therefore, as we have previously found that hypoxia could 
activate autophagy after endurance exercise (28), we investigated whether the same occurred 
after resistance exercise. Initiation of autophagy through LC3b lipidation was highly activated 
by the nutritional state, inversely following insulin levels, and partially reversed by resistance 
exercise. However, hypoxia had no influence on those regulations on LC3bII/I, nor on p62 
expression, which remained unaltered by any condition. Those results contrast with our 
previous study (28), probably because the hypoxic conditions were less severe here. The level 
of oxygen was higher here (14% vs.11%) and the duration much shorter (30min vs. 8h), 
indicating that moderate hypoxia does not influence the post-translational regulation of 
autophagy. Unexpectedly after such short exposure duration, hypoxia down-regulated the 
expression of a series of genes that compose the so-called transcriptional response of 
autophagy, amongst which Lc3b and Bnip3. Usually, the transcriptional response is activated 
when autophagy lasts for hours or days to replenish the components of the machinery (32). 
The lower mRNA levels of Lc3b and Bnip3 in hypoxia are therefore surprising and opposite 
to the regulation of FoxO. The latter activates autophagy at both the post-translational and 
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transcriptional levels (32). Here, FoxO phosphorylation was higher in hypoxia but did not 
translate into an activation of autophagy at any level. It still remains to determine why Lc3b 
and Bnip3 mRNA levels were lower, and except a regulation of their stability by hypoxia, no 
other explanation can be put forward. In summary, moderate hypoxia down-regulated the 
expression of a series of genes involved in the transcriptional response of autophagy without 
impacting the initiation of the process as measured by the unchanged LC3bII/I ratio in 
hypoxic compared to normoxic conditions. 
The micorarray analyses revealed that hypoxia regulated the expression of genes involved in 
glucose metabolism at rest, and genes involved in myoblast differentiation and fusion, and in 
muscle contraction machinery after exercise. This is the first microarray analysis reporting the 
transcriptional regulation induced by a single exposure to environmental hypoxia in human 
skeletal muscle. The higher expression of genes involved in glucose metabolism at rest is not 
surprising, as a better glucose handling (33) and higher dependence on blood glucose (34, 35) 
have been shown in people living at moderate to high altitude. Here, we show that a single 
exposure of 30min is enough to initiate those adaptations at a transcriptional level, confirming 
previous results from our lab showing a higher abundance of GLUT4 at the sarcolemmal 
membrane after 4h of hypoxic exposure (36). After exercise, genes involved in myoblast 
differentiation and fusion, and in muscle contraction machinery were differently regulated in 
hypoxia compared to normoxia. Globally, genes related to the slow phenotype were down-
regulated, such as troponin I1 and troponin T1, whereas those related to the fast phenotype 
were-upregulated, such as troponin T3 and MYH1. Studies having looked at fiber typing 
before and after hypoxic exposure in human are scarce and data are not straightforward. In 
addition, the role of physical activity in those adaptations is unclear. One study found no 
change in myosin heavy chain type I and type IIx mRNA levels after 6 weeks of endurance 
training (37), while another study found an increase in type I and a decrease in type IIx 
protein expression after a 43-day Himalayan expedition (38). However, the higher mRNA 
level we observed for MYH1, which encodes for myosin heavy chain type IIx, is a positive 
molecular response to resistance exercise, which requires explosive and powerful muscle 
contractions. Whether this will translate into higher protein content and better performance 
needs to be investigated with a training study.  
Environmental hypoxia regulates myogenesis during embryonic developement, myoblasts and 
satellite cell proliferation and differentiation (39). Here, we were particularly interested in the 
effect of hypoxia on the proliferation of satellite cells and their differentiation into myoblasts. 
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Both processes are tightly regulated by the myogenic regulatory factors. Myf5 and MyoD are 
expressed upon activation and proliferation of satellite cells (40). MyoD remains expressed at 
early stages of differentiation and myogenin, followed by Mrf4, at a later stage (40). In vitro, 
low oxygen levels (3-6%) seem to favor myoblast proliferation, whereas very low oxygen 
levels (<1%) tend to alter myogenic differentiation and myotube formation (41). Murine 
myoblasts cultured in a severe hypoxic environment (1% O2) have been shown to up-regulate 
the expression of genes related to cell cycle and metabolic processes and to down-regulate the 
expression of genes associated with catabolic processes and muscle development (42). Our 
results contrast with the aforementioned studies as no effect of hypoxia was found on specific 
markers for cell proliferation such as Cyclin D1, Pcna or p21 whereas hypoxia increased the 
expression of some markers for cell differentiation. Both the microarray and the qPCR 
analyses showed that the mRNA levels of myogenin were higher in hypoxia compared to 
normoxia. In addition, a trend to an increase was observed for MyoD and Mrf4 mRNA. If this 
translates at the protein level, a well-controlled dose of hypoxia would favor satellite cell 
incorporation and differentiation into existing myofibres, which could be a mechanism 
contributing to the increased muscle mass after intermittent and moderate hypoxia previously 
reported in human (8). 
Whether HIF-1α is responsible for the regulation of protein metabolism and satellite cells 
under hypoxic conditions is currently unknown. In vitro, HIF-1α and the mTORC1 pathway 
have been shown to regulate each other (43-45), but this has not been confirmed in vivo. Data 
on intramuscular pO2 are sparse, but a critical threshold of 7-8 mmHg has been suggested 
below which intramuscular HIF-1α accumulates (46). When humans are passively exposed to 
environmental hypoxia, the drop in intramuscular pO2 does not surpass this threshold (47) and 
HIF-1α does not stabilize as we previously showed (27). Contrarily, HIF-1α can be stabilized 
during repeated muscle contractions in humans, which are known to largely decrease 
intramuscular pO2 (47), coupled or not to blood flow restriction (3). Here, the tissue saturation 
index decreased by about 10% during resistance exercise, but no additional effect of hypoxia 
was observed. It seems therefore that repeated contractions or endurance exercise is more 
potent to stabilize HIF-1α than resistance exercise. Of note, no decrease in tissue oxygenation 
index was detected under hypoxia, probably because 14% O2 was not severe enough as 
skeletal muscle is a potent tissue to face a lack of oxygen. Therefore, the molecular 
regulations observed in the present study after resistance exercise and/or hypoxia were 
probably independent of the HIF-1α pathway as HIF-1α was not stabilized and the expression 
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of downstream target genes (Vegf, Redd1, Lox and Plin2 mRNA) was not increased at the 
two time points analyzed here. 
The strength of the present study is the direct measurement of protein synthesis and 
degradation together with the quantification of commonly used markers to assess these 
processes. The microarray data provide new perspectives in terms of further investigation and 
more particularly at the level of satellite cells. The main limitation of the present study is the 
absence of muscle biopsy before the exercise session, as the protocol already comprised four 
muscle biopsies within a period of four hours. Thus, we cannot exclude a systemic effect from 
the exercised to the rested leg since both biopsies were taken at the same time. This said, we 
were mainly interested in the effect of hypoxia, which could be properly studied by 
comparison to the normoxic condition. 
All together, we conclude that, contrary to our hypothesis, environmental hypoxia did not 
potentiate the short-term anabolic response after resistance exercise, but it initiated 
transcriptional regulations that could potentially translate into satellite cells incorporation and 
higher force production on the long-term, which remains to be investigated.  
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Tables 
Table 1. Primer sequences 
 
Forward Reverse 
Atg12 AGT AGA GCG AAC ACG AAC CAT C CCA TCA CTG CCA AAA CAC TCA T 
Bnip3 CTG AAA CAG ATA CCC ATA GCA TT CCG ACT TGA CCA ATC CCA 
Bnip3L CCA AGG AGT TCC ACT TCA GAC AGT AGG TGC TGG CAG AGG GTG T 
Cyclin D1 GAA CAA GCT CAA GTG GAA CC CAC AGA GGG CAA CGA AGG 
Fos GGC AAG GTG GAA CAG TTA TC TCT CCG CTT GGA GTG TAT C 
Hif-1α GCC CCA GAT TCA GGA TCA GA TGG GAC TAT TAG GCT CAG GTG 
Hif-2α AAG CTG AAG CGA CAG CTG GAG TAT GTA CAT TTG CGC TCA GTG GCT TGT 
Lc3b AAT CCC GGT GAT AAT AGA ACG A GGA GAC GCT GAC CAT GCT GT 
Lox GCA CAG TTG TCA TCA ACA TTA C GAT GTC CTG TGT AGC GAA TG 
Mafbx CGA CCT CAG CAG TTA CTG CAA TTT GCT ATC AGC TCC AAC AG 
Mrf4 AAT CTT GAG GGT GCG GAT TTC CTG TGC TCC TCC TTC CTT AGC CGT TAT 
Murf-1 AAA CAG GAG TGC TCC AGT CGG CGC CAC CAG CAT GGA GAT ACA 
Myf5 TGA GAG AGC AGG TGG AGA ACT ACT AGA CAG GAC TGT TAC ATT CGG GCA 
Myh1 CAC ACT AGT TTC ACA GCT CTC GGC ACT CTT GGC CTT TAT C 
Myh11 GGA GGA GCA GCT ATC CAT ATT GCC TGG TCT GTG TTT CTT TC 
MyoD TGC CAC AAC GGA CGA CTT CTA TGA AAG TGC GAG TGC TCT TCG GGT TT 
Myogenin AAA CTA CCT GCC TGT CCA CCT C ACA CCG ACT TCC TCT TAC ACA CCT 
p21 GCA GAC CAG CAT GAC AGA TTT GGA TTA GGG CTT CCT CTT GGA 
Pcna ATC CTC AAG AAG GTG TTG GAG GCA ACG AGT CCA TGC TCT GCA GGT TTA 
Pdk4 CAG CTA CTG GAC TTT GGT TC CTA ATT GGG TCG GGA GGA TA 
Pfk ATT TGA CGA AGC CCT GAA G GTG CGA ACC ACT CTT AGA TAC 
Plin2 CTC ATG TCC TCA GCC TAT CT TAG GCA GTC TCT CCT CAA TC 
Rpl19 CGC TGT GGC AAG AAG AAG GTC GGA ATG GAC CGT CAC AGG C 
Rpl4 ATA CGC CAT CTG TTC TGC CCT GCT TCC TTG GTC TTC TTG TAG CCT 
Tnni1 CAA CAC CAG GGA GAT TAA GG ATG GAC ACC TTG TGC TTG 
Tnnt1 GAG CTG TCG GAC TGG AT ACA GCA CGT TGA TCT CAT ATT 
Vegf TTT CTG CTG TCT TGG GTG CAT TGG ACC ACT TCG TGA TGA TTC TGC CCT 
Atg12, autophagy-related protein 12; Atg4b, autophagy-related protein 4b; Bnip3, Bcl-
2/adenovirus E1B 19 kDa protein-interacting protein 3; Bnip3L, Bnip3 like; Hif-1α, hypoxia-
inducible factor 1 alpha; Hif-2α, hypoxia-inducible factor 2 alpha; Lc3b, microtubule-
associated proteins 1A/1B light chain 3B; Lox, lipoxygenase; Mafbx, muscle atrophy F box; 
Mrf4, muscle regulatory factor 4; Murf-1, muscle ring finger protein-1; Myf5, myogenic 
factor 5; Myh1, myosin heavy chain IIx/D; Myh11, myosin heavy chain polypeptide 11, 
smooth muscle; Pcna, proliferating cell nuclear antigen; Pdk4, pyruvate dehydrogenase kinase 
isoform 4; Pfk, phosphofructokinase; Plin2, perilipin 2; Redd1, protein regulated in 
development and DNA damage response 1; Rpl19, ribosomal protein L19; Rpl4, ribosomal 
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protein L4; Tnni1, troponin I1, slow skeletal type; Tnnt1, troponin T1, slow skeletal type; 
Vegf, vascular endothelial growth factor.  
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Table 2. Tissue oxygenation and heart rate during exercise 
 
SpO2 (%) TSI (%) HR (beats/min) 
 NOR HYP NOR HYP NOR HYP 
Baseline 98.2 ± 0.1 93.3 ± 0.4
*** 61.3 ± 0.9 61.4 ± 0.8  73.2 ± 3.1  85.1 ± 4.2  
Set 1  98.2 ± 0.2 93.1 ± 0.4
*** 48.8 ± 1.1### 50.4 ± 1.5### 92.6 ± 2.3### 101.6 ± 3.6### 
Set 2  98.0 ± 0.1 94.6 ± 0.3
#,*** 51.1 ± 1.1### 49.4 ± 1.9### 93.3 ± 3.5### 100.5 ± 4.6### 
Set 3  98.0 ± 0.1 95.1 ± 0.4
###,*** 50.3 ± 1.3### 50.1 ± 1.8### 92.5 ± 4.1### 101.2 ± 5.1### 
Set 4  98.0 ± 0.1 94.9 ± 0.5
#,*** 51.8 ± 1.4### 50.5 ± 1.7### 95.5 ± 3.3### 101.7 ± 4.7### 
Set 5  98.3 ± 0.1 94.7 ± 0.3
#,*** 50.9 ± 1.1### 50.6 ± 1.8### 98.8 ± 3.9### 104.6 ± 5.3### 
Set 6 98.3 ± 0.1 95.1 ± 0.4
###,*** 52.4 ± 0.9### 51.4 ± 1.5### 97.4 ± 4.5### 106.7 ± 5.1### 
Set 7 98.4 ± 0.1 94.9 ± 0.4
#,*** 52.5 ± 0.9### 52.4 ± 1.7### 102.6 ± 4.8### 106.7 ± 4.6### 
Set 8 98.4 ± 0.1 94.6 ± 0.5
#,*** 54.0 ± 0.7### 52.5 ±1.6### 106.2 ± 6.1### 109.3 ± 5.1### 
SpO2, blood oxygenation; TSI, tissue saturation index; HR, heart rate; NOR, normoxia; HYP, 
hypoxia. 
#
p<0.05, 
###
p<0.001 vs Baseline; 
*
p<0.05, 
***
p<0.001 vs NOR. 
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Table 3. Plasma insulin and cortisol concentrations 
 
 
Fasted Post 2h Post 4h Post 
Insulin NOR 2.7 ± 0.5 12.3 ± 2.2
### 2.5 ± 0.5 1.9 ± 0.3 
(mIU/ml) HYP 2.8 ± 0.4 15.6 ± 1.9
### 4.9 ± 1.2 2.4 ±0.4 
Cortisol NOR 273 ± 33 167 ± 25
### 120 ± 17## 128 ± 26### 
(ng/ml) HYP 245 ± 29 160 ± 22
# 138 ± 19### 139 ± 19### 
NOR, normoxia; HYP, hypoxia. 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 vs Fasted 
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Figure legends 
Figure 1. Study protocol 
NIRS, near infrared spectroscopy; TSI, tissue saturation index; SpO2, peripheral blood oxygen 
saturation; HR, heart rate; Ex, exercise; R, right; L, left. 
 
Figure 2. Regulation of the fractional protein synthetic rate and protein synthesis 
markers by hypoxia and exercise 
(a) Fractional protein synthetic rate between 15min and 4h post-exercise in the control and the 
exercised leg in normoxia and hypoxia. Phosphorylation of (b) Akt Ser
473
, (c) S6K1 Thr
389
, 
(d) S6 Ser
235/236
, (f) AMPK Thr
172
 and (g) ACC Ser
79
 and (e) protein expression of Redd1 in 
the control and in the exercised leg at Post and at 4h Post in normoxia and hypoxia. (h) 
Representative western blots. NOR, normoxia; HYP, hypoxia; Ctrl, control leg; Ex, exercised 
leg; FSR, fractional synthetic rate. *p<0.05, ***p<001 HYP vs NOR; 
$
p<0.05, 
$$
p<0.01 Ex vs 
Ctrl; 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 4h Post vs Post. n = 10/group. 
 
Figure 3. Regulation of the protein degradation rate and protein degradation markers 
by hypoxia and exercise 
(a) Protein degradation rate between 15min and 4h post-exercise in normoxia and hypoxia. (b) 
LC3bII/I ratio, (c) p62 protein expression, (d) Bnip3 mRNA levels, (e) Bnip3L mRNA levels, 
(f) Lc3b mRNA levels, (g) Atg12 mRNA levels, (h) FoxO1 Thr
24
/FoxO3a Thr
32
 
phosphorylation, (i) Murf-1 mRNA levels and (j) Mafbx mRNA levels in the control and in 
the exercised leg at Post and at 4h Post in normoxia and hypoxia. (k) Representative western 
blots. NOR, normoxia; HYP, hypoxia; Ctrl, control leg; Ex, exercised leg; D-3MH: 3D-
methyl-histidine. *p<0.05, **p<0.01 HYP vs NOR; 
$
p<0.05 Ex vs Ctrl; 
#
p<0.05, 
##
p<0.01 4h 
Post vs Post. n = 10/group. 
 
Figure 4. Regulation of gene expression by hypoxia and exercise 
(a) Heat map with selected genes >1.5-fold up- or down-regulated in hypoxia vs. normoxia in 
the control (Re) and the exercised (Ex) legs. Gene ontology by DAVID web tool using the 
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genes >1.5-fold up- or down-regulated in hypoxia vs. normoxia in the control (b) and in the 
exercised (c) legs; only significantly modified terms are presented, as −log10(p-value) > 1.3 
(Fischer exact p-value). Percentage of intersection represents the percentage of genes 
regulated in hypoxia vs. normoxia in relation to the genes in the DAVID database. n = 8 in 
normoxia and n = 7 in hypoxia. BP, biological process; CC, cellular component; GO, gene 
ontology; MF, molecular function. 
 
Figure 5. Regulation of the myogenic regulatory factors by hypoxia and exercise 
(a) Fos, (b) Cyclin D1, (c) Pcna, (d) p21, (e) Myf5, (f) MyoD, (g) Myogenin and (h) Mrf4 
mRNA levels in the control and in the exercised leg at Post and at 4h Post in normoxia and 
hypoxia. NOR, normoxia; HYP, hypoxia; Ctrl, control leg; Ex, exercised leg. *p<0.05, 
**p<0.01 HYP vs NOR; 
$
p<0.05, 
$$
p<0.01, 
$$$
p<0.001 Ex vs Ctrl; 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 4h Post vs Post. n = 10/group. 
 
Figure 6. Regulation of the hypoxia-inducible factor 1 alpha pathway by hypoxia and 
exercise 
(a) HIF-1α localization and representative western blots of HIF-1α and eEF2, (b) HIF-1α 
protein expression, (c) Hif-1α, (d) Hif-2α, (e) Vegf, (f) Lox and (g) Plin2 mRNA levels in the 
control and in the exercised leg at Post and at 4h Post in normoxia and hypoxia. NOR, 
normoxia; HYP, hypoxia; Ctrl, control leg; Ex, exercised leg. 
$
p<0.05, 
$$$
p<0.001 Ex vs Ctrl; 
#
p<0.05, 
##
p<0.01 4h Post vs Post. n = 10/group. 
 
Supplementary file 1 
Detailed report of the microarray analyses. 
Supplementary file 2 
(a) Myh1, (b) Myh11, (c) Tnni1, (d) Tnnt1, (e) Pfk and (f) Pdk4 mRNA levels in the control 
and in the exercised leg at Post and at 4h Post in normoxia and hypoxia. NOR, normoxia; 
HYP, hypoxia; Ctrl, control leg; Ex, exercised leg. *p<0.05 HYP vs NOR; 
$
p<0.05, 
$$
p<0.01, 
$$$
p<0.001 Ex vs Ctrl; 
#
p<0.05, 
###
p<0.001 4h Post vs Post. n = 10/group. 
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Supplementary file 3 
Cobald cloride (CoCl2) 400 μM for 24h was used as a positive control to validate the antibody 
used to localize HIF-1α as well as the technique for immunofluorescence in (a) HeLa cells 
and (b) human myotubes.  
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Table 1. Primer sequences 
 
Forward Reverse 
Atg12 AGT AGA GCG AAC ACG AAC CAT C CCA TCA CTG CCA AAA CAC TCA T 
Bnip3 CTG AAA CAG ATA CCC ATA GCA TT CCG ACT TGA CCA ATC CCA 
Bnip3L CCA AGG AGT TCC ACT TCA GAC AGT AGG TGC TGG CAG AGG GTG T 
Cyclin D1 GAA CAA GCT CAA GTG GAA CC CAC AGA GGG CAA CGA AGG 
Fos GGC AAG GTG GAA CAG TTA TC TCT CCG CTT GGA GTG TAT C 
Hif-1α GCC CCA GAT TCA GGA TCA GA TGG GAC TAT TAG GCT CAG GTG 
Hif-2α AAG CTG AAG CGA CAG CTG GAG TAT GTA CAT TTG CGC TCA GTG GCT TGT 
Lc3b AAT CCC GGT GAT AAT AGA ACG A GGA GAC GCT GAC CAT GCT GT 
Lox GCA CAG TTG TCA TCA ACA TTA C GAT GTC CTG TGT AGC GAA TG 
Mafbx CGA CCT CAG CAG TTA CTG CAA TTT GCT ATC AGC TCC AAC AG 
Mrf4 AAT CTT GAG GGT GCG GAT TTC CTG TGC TCC TCC TTC CTT AGC CGT TAT 
Murf-1 AAA CAG GAG TGC TCC AGT CGG CGC CAC CAG CAT GGA GAT ACA 
Myf5 TGA GAG AGC AGG TGG AGA ACT ACT AGA CAG GAC TGT TAC ATT CGG GCA 
Myh1 CAC ACT AGT TTC ACA GCT CTC GGC ACT CTT GGC CTT TAT C 
Myh11 GGA GGA GCA GCT ATC CAT ATT GCC TGG TCT GTG TTT CTT TC 
MyoD TGC CAC AAC GGA CGA CTT CTA TGA AAG TGC GAG TGC TCT TCG GGT TT 
Myogenin AAA CTA CCT GCC TGT CCA CCT C ACA CCG ACT TCC TCT TAC ACA CCT 
p21 GCA GAC CAG CAT GAC AGA TTT GGA TTA GGG CTT CCT CTT GGA 
Pcna ATC CTC AAG AAG GTG TTG GAG GCA ACG AGT CCA TGC TCT GCA GGT TTA 
Pdk4 CAG CTA CTG GAC TTT GGT TC CTA ATT GGG TCG GGA GGA TA 
Pfk ATT TGA CGA AGC CCT GAA G GTG CGA ACC ACT CTT AGA TAC 
Plin2 CTC ATG TCC TCA GCC TAT CT TAG GCA GTC TCT CCT CAA TC 
Rpl19 CGC TGT GGC AAG AAG AAG GTC GGA ATG GAC CGT CAC AGG C 
Rpl4 ATA CGC CAT CTG TTC TGC CCT GCT TCC TTG GTC TTC TTG TAG CCT 
Tnni1 CAA CAC CAG GGA GAT TAA GG ATG GAC ACC TTG TGC TTG 
Tnnt1 GAG CTG TCG GAC TGG AT ACA GCA CGT TGA TCT CAT ATT 
Vegf TTT CTG CTG TCT TGG GTG CAT TGG ACC ACT TCG TGA TGA TTC TGC CCT 
Atg12, autophagy-related protein 12; Atg4b, autophagy-related protein 4b; Bnip3, Bcl-
2/adenovirus E1B 19 kDa protein-interacting protein 3; Bnip3L, Bnip3 like; Hif-1α, hypoxia-
inducible factor 1 alpha; Hif-2α, hypoxia-inducible factor 2 alpha; Lc3b, microtubule-
associated proteins 1A/1B light chain 3B; Lox, lipoxygenase; Mafbx, muscle atrophy F box; 
Mrf4, muscle regulatory factor 4; Murf-1, muscle ring finger protein-1; Myf5, myogenic 
factor 5; Myh1, myosin heavy chain IIx/D; Myh11, myosin heavy chain polypeptide 11, 
smooth muscle; Pcna, proliferating cell nuclear antigen; Pdk4, pyruvate dehydrogenase kinase 
isoform 4; Pfk, phosphofructokinase; Plin2, perilipin 2; Redd1, protein regulated in 
development and DNA damage response 1; Rpl19, ribosomal protein L19; Rpl4, ribosomal 
protein L4; Tnni1, troponin I1, slow skeletal type; Tnnt1, troponin T1, slow skeletal type; 
Vegf, vascular endothelial growth factor. 
Table 2. Tissue oxygenation and heart rate during exercise 
 SpO2 (%) TSI (%) HR (beats/min) 
 NOR HYP NOR HYP NOR HYP 
Baseline 98.2 ± 0.1 93.3 ± 0.4*** 61.3 ± 0.9 61.4 ± 0.8  73.2 ± 3.1  85.1 ± 4.2  
Set 1  98.2 ± 0.2 93.1 ± 0.4*** 48.8 ± 1.1### 50.4 ± 1.5### 92.6 ± 2.3### 101.6 ± 3.6### 
Set 2  98.0 ± 0.1 94.6 ± 0.3#,*** 51.1 ± 1.1### 49.4 ± 1.9### 93.3 ± 3.5### 100.5 ± 4.6### 
Set 3  98.0 ± 0.1 95.1 ± 0.4###,*** 50.3 ± 1.3### 50.1 ± 1.8### 92.5 ± 4.1### 101.2 ± 5.1### 
Set 4  98.0 ± 0.1 94.9 ± 0.5#,*** 51.8 ± 1.4### 50.5 ± 1.7### 95.5 ± 3.3### 101.7 ± 4.7### 
Set 5  98.3 ± 0.1 94.7 ± 0.3#,*** 50.9 ± 1.1### 50.6 ± 1.8### 98.8 ± 3.9### 104.6 ± 5.3### 
Set 6 98.3 ± 0.1 95.1 ± 0.4###,*** 52.4 ± 0.9### 51.4 ± 1.5### 97.4 ± 4.5### 106.7 ± 5.1### 
Set 7 98.4 ± 0.1 94.9 ± 0.4#,*** 52.5 ± 0.9### 52.4 ± 1.7### 102.6 ± 4.8### 106.7 ± 4.6### 
Set 8 98.4 ± 0.1 94.6 ± 0.5#,*** 54.0 ± 0.7### 52.5 ±1.6### 106.2 ± 6.1### 109.3 ± 5.1### 
SpO2, blood oxygenation; TSI, tissue saturation index; HR, heart rate; NOR, normoxia; HYP, 
hypoxia. #p<0.05, ###p<0.001 vs Baseline; *p<0.05, ***p<0.001 vs NOR. 
 	
Table 3. Plasma insulin and cortisol concentrations 
 
 
Fasted Post 2h Post 4h Post 
Insulin NOR 2.7 ± 0.5 12.3 ± 2.2
### 2.5 ± 0.5 1.9 ± 0.3 
(mIU/ml) HYP 2.8 ± 0.4 15.6 ± 1.9
### 4.9 ± 1.2 2.4 ±0.4 
Cortisol NOR 273 ± 33 167 ± 25
### 120 ± 17## 128 ± 26### 
(ng/ml) HYP 245 ± 29 160 ± 22
# 138 ± 19### 139 ± 19### 
NOR, normoxia; HYP, hypoxia. 
#
p<0.05, 
##
p<0.01, 
###
p<0.001 vs Fasted 
 
 
